Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.» Read More
A French government research agency shows that putting off retirement can delay dementia. Dr. Nancy Snyderman, NBC's chief medical editor, explains the "use it or lose it" strategy.
"Harry Potter" magic? No, it's acoustic levitation. Researchers have created a device that uses sound waves to make small solid objects and liquid droplets float in the air.
Fred Hutchinson Cancer Research Center released a study revealing men with concentrations of omega-3 fatty acids have an increased risk of prostate cancer. Co-author Alan Kristal shares more from their study on the best selling supplement.
Genetically modified seeds are used in corn and soybeans grown in the US, but the debate over the effects of tinkering with Mother Nature hasn't gone away.
A panel of experts and Larry Kudlow discuss the Supreme Court's refusal to declare "pay to delay" deals between pharmaceutical companies and generic drugmakers illegal.
Last year $2 billion worth of products were sold with a label saying they do not contain ingredients from genetically modified organisms, but the claim wasn't backed by regulators.
Steve Green, Chevron vp of public affairs, talks about a new educational video series produced for grades K through 12, which examines the role of technology and engineering in the game of golf.
The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.
In a unanimous decision, the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Hampton Pearson.
Discussing the big problems Obamacare creates for hospitals, doctors, and even medical students, with Dr. Beth Haynes M.D. of Benjamin Rush Society, Brian Blank, UNC-Chapel Hill Medical Student.
Monsanto is not pushing for expansion of genetically modified crops in most of Europe as opposition to its biotech seeds in many countries remains high, company officials said.
CNBC's Jane Wells reports the name of the asteroid flying by Earth is "1998 QE2," and it won't get any closer to Earth than 3.6 million miles.
Bristol-Myers is presenting data on its next-generation drug Nivolumab, which treats tumors, reports CNBC's Bertha Coombs.
Asteroid alert! CNBC's Jane Wells reports on the asteroid passing by Earth today.
Gilead is taking aim at cancer, and the company is presenting early-stage data at the oncology conference on treatment for blood cancer, reports CNBC's Bertha Coombs.
There's a big asteroid that's due to sail past Earth on Friday, and it comes with a moon twice as big as the ocean liner that shares the meteor's name.
The cost of sequencing DNA has plunged from $100 million in 2001 to less than $10,000 today. Amit Bhalla, Citi, offers insight on the developing technologies for personalized care.
A letter Francis Crick wrote shortly after the discovery of the structure of DNA sold at Christie's for a whopping $5.3 million.
CNBC's Herb Greenberg reports on the question facing Intuitive Surgical. The company alerted hospitals of a potential issue with one of its instruments.
Researchers have declared a new species of dinosaur found in northwestern China. The GlobalPost reports.